Takeda Pharmaceutical (TAK) Change in Cash (2018 - 2026)

Takeda Pharmaceutical's Change in Cash history runs 9 years deep, the most recent figure standing at -$388.9 million for Q1 2026.

• In Q1 2026, Change in Cash rose 40.26% year-over-year to -$388.9 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 378.88% YoY), while the FY2026 annual figure was $1.2 billion, up 389.65% from the prior year.
• Change in Cash was -$388.9 million for Q1 2026 at Takeda Pharmaceutical, down from -$318.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.2 billion in Q3 2025 to a low of -$2.6 billion in Q4 2024.
• Historically, Change in Cash has averaged -$100.8 million across 5 years, with a median of -$225.8 million in 2025.
• Biggest YoY gain for Change in Cash was 4082.0% in 2024; the steepest drop was 1318.61% in 2024.
• A 5-year view of Change in Cash shows it stood at -$732.0 million in 2022, then jumped by 75.44% to -$179.8 million in 2023, then plunged by 1318.61% to -$2.6 billion in 2024, then soared by 87.52% to -$318.4 million in 2025, then declined by 22.15% to -$388.9 million in 2026.
• The last three Change in Cash figures came in at -$388.9 million (Q1 2026), -$318.4 million (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.